Lv1
50 积分 2025-08-15 加入
BMS-986458 a Potential First-in-Class, Highly Selective, Potent and Well Tolerated BCL6 Ligand Directed Degrader (LDD) Demonstrates Multi-Modal Anti-Tumor Efficacy for the Treatment of B-Cell Non-Hodgkin's Lymphoma
6个月前
已完结
不同动物尿液采集的方法及意义
7个月前
已完结
Targeting spleen tyrosine kinase (SYK): structure, mechanisms and drug discovery
10个月前
已完结
Discovery of INCB123667, a potent and selective cyclin-dependent kinase 2 (CDK2) inhibitor for the treatment of cyclin E dysregulated cancers
10个月前
已完结
Discovery of potent and selective CDK2 inhibitors with high safety and favorable bioavailability for the treatment of cancer
10个月前
已完结
皖公网安备34019202002308
